PAXBP1 and cancer: These included the lncRNA NNT-AS1, which is upregulated in several cancers and associated with poor overall survival [52], the lncRNA MKLN1-AS, which is overexpressed in hepatocellular carcinoma with poor prognosis [53], the lncRNA LINC01206, whose expression is increased in samples of squamous cell carcinoma of the lung [54], and PAXBP1-AS1, whose dysregulation has been observed in triple-negative breast cancer [55].